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ABSTRACT
INTRODUCTION: Hyperuricemia is a cardiovascular 
disease risk factor that has been poorly researched into in 
Africa and its prevalence is largely unknown in the rural 
areas in Nigeria and in the Niger Delta region of Nigeria 
in particular. 
METHODS: A cross-sectional rural survey involving 
500 subjects aged 15 years and above. Demographic and 
social data were obtained using a questionnaire. 
Anthropometric (height, weight, waist circumference) 
and blood pressure measurements were taken. Blood 
samples were taken for blood uric acid, glucose and lipid 
check. 
RESULTS: The mean age of the study subjects was 
41.32±17.0 (males, 42.84±17.8; females, 40.62±16.6) 
with a range of 15 years to 95 years. The male to female 
ratio was 1:2.3. The mean serum uric acid was 
337.58±94.59 mmol/l with a significant higher mean for 
females (males 333.20±88.70, females 339.56±97.21, 
p<0.001).  Hyperuricemia was found in 86 subject 
giving a prevalence of 17.2 % with higher prevalence in 
2 
males (males 25%, females 13.7%; x = 7.75, p= 0.006). 
Correlational analysis of serum uric acid with other 
parameters revealed that waist circumference, total 
cholesterol, low-density lipoprotein and gender had 
significant association with uric acid. Male gender was 
found to be a significant predictor for hyperuricaemia 
following a logistic regression.
CONCLUSION: The prevalence of hyperuricemia is 
high in this rural community of study. There is need for 
more research considering the cardiovascular and other 
implications of hyperuricaemia.
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INTRODUCTION
Serum uric acid level which is a final product of purine 
metabolism and a function of the balance between the 
breakdown of purines and the rate of uric acid excretion 
is beginning to gain prominence globally as both a risk 
factor for cardiovascular disease and its involvement in 
1-3
metabolic and kidney diseases.  Several physiologic 
and environmental factors have been reported to be 
associated with the prevalence of hyperuricaemia. 
Among such are geographical location, socio-economic 
4-5.
status, age, sex, and race. The increased risk of 
 
cardiovascular disease observed with westernization of 
 native peoples, immigration to Western countries, and 
 
movement from rural to urban communities also 
6 
correlates with increased uric acid levels. Women tend 
 to have lower levels (by0.5 to 1.0 mg per decilitre [30 to 
 
60 µmol per litre]) than men, probably because of the 
7  
uricosuric effect of estrogens.
Hyperuricemia  is a cardiovascular disease risk factor 
that has been poorly researched into in Africa even 
though it has strong association with the development of 
8cardiovascular diseases.  Hyperuricemia is  also a major 
9-10risk factor for gout,  and is implicated in the etiology 
11-16of some degenerative diseases.  There is a growing 
data on the rising  incidence of gout internationally 
particularly among the middle-aged and older people 
and westernization of lifestyle is said to be associated 
17-19
with this rising incidence.  Globally,  researchers have 
reported various prevalence rates ranging from 5% to 
2062%.  The prevalence of hyperuricemia is however 
largely unknown in Nigeria and in the Niger Delta 
21 
region of Nigeria in particular. In 2005, Isezuo et al
reported a prevalence of 32.3% among diabetic patients 
in Nigeria which is higher than the 25% reported by 
Ogbera  e t  a l   i n  2010  among  Niger i an  
22
diabetics. However there is paucity of data on rural-
urban dichotomy as most of the published works were 
mainly urban and hospital based. Hence there is need to 
study the prevalence of this increasingly important 
cardiovascular risk factor in a homogenous rural 
community setting.
The purpose of this present research is to determine both 
the prevalence and predictors of hyperuricaemia in a 
rural community in the Niger Delta region of Nigeria.
MATERIALS AND METHODS
This is a cross sectional survey conducted in Mba, a rural 
community in Etche local government area of Rivers 
state in Niger Delta region of Nigeria involving 500 
subjects aged 15 years and above. Approval of the Ethics 
committee of the University of Port Harcourt Teaching 
Hospital was obtained. Consent from the village Chiefs 
was also obtained. 
Demographic and social information including age, 
gender, occupation, educational level, cigarette 
smoking, alcohol consumption and level of physical 
activity were obtained using a questionnaire 
administered by face-to-face interview. Anthropometric 
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(height, weight, waist circumference) and blood 
pressure measurements were done in a standardized 
manner.  Readings were taken to the nearest 0.1 kg for 
weight and nearest 0.1cm for height. Body mass index 
(BMI) was calculated as weight in kilogram divided by 
the square of height in meters. Midway between the 
uppermost border of the iliac crest and the lower border 
of the costal margin (rib cage) served as the  position for 
23
measuring waist circumference.  Hip circumference 
was measured in a  horizontal plane at the maximum 
23width over the greater trochanter.   Blood pressure was 
measured using a mercury sphygmomanometer.
Fasting venous blood samples were obtained from study 
subjects. Plasma samples were  conveyed to the 
Chemical department laboratory of University of Port 
Harcourt Teaching hospital, subsequently centrifuged.  
Venous blood Glucose was measured by the Glucose 
oxidase method. Plasma total cholesterol and 
triglycerides were determined by the Colorimetric 
enzymatic methods,(Randox laboratories ltd, Crumlin, 
Co. Antrim, United Kingdom). Plasma high density 
lipoprotein cholesterol (HDL cholesterol) were 
measured by the same enzymatic method after 
precipitation. Low density lipoprotein (LDL 
cholesterol) was estimated according to the formula 
LDL cholesterol = total cholesterol  HDL cholesterol - 
triglycerides/2.2. Uric acid was also analysed using 
enzymatic method.  
Hypertension was defined using the JNC 7 (Joint 
National Committee on Prevention, Evaluation, and 
Treatment report) criteria of blood pressure = 140/90 
mmHg or self-reported anti hypertensive medication 
25use.  Diabetes mellitus was defined using fasting 
26plasma glucose (FPG) = 7.0 mmol/l (126 mg/dl)  and 
individuals who were previously known to have 
diabetes based on history of drug medication were also 
classified to have diabetes. Total cholesterol of > 
6mmol/L, TG > 1.8mmol/L, HDL-C <1.0mmol/L and 
LDL-C = 3mmol/L were taken as abnormal values. 
Hyperuricemia was defined as =420mmol/L for males 
27 
and =360 mmol/L for females. Waist Circumference 
equal to or greater than 102cm in males and 88cm in 
females were taken as abnormal. Abdominal obesity 
will be represented or assessed by waist circumference.
Statistical analysis was done using Statistical Package 
for Social Sciences (SPSS Inc, Chicago,IL) version 17. 
Results were expressed as either mean values (standard 
deviation) or proportions. Comparison for statistical 
significance was by student's t test for Continuous 
variables and chi-square analysis for categorical 
variables. Epi info statistical package version 3.5.1 was 
used for chi-square for trend analysis. Pearson and 
Spearman' rho correlation test were used to determine 
the relationship between hypertension and its possible 
risk factors. Multivariate logistic regression was also 




The overall mean age of the study subjects was 
41.32±17.0 with a range of 15 years to 95 years. The 
mean age for males was 42.84±17.8 and that for females 
was 40.62±16.6 with a statistically significant 
difference (P<0.001) as shown in Table 1. 
SBP = systolic blood pressure; DBP= diastolic blood 
pressure; BMI= Body mass index; WC = Waist 
circumference; TC= total cholesterol ; TG= 
triglycerides; HDL= High density lipoprotein; LDL= 
Low density lipoprotein; N= number;  P* = Significant 
Likewise as also shown in Table 1, mean BMI, mean 
waist circumference and the mean systolic blood 
pressure showed significant gender differences amongst 
the study subjects. The male to female ratio was 
1:2.3.The mean age for subjects with hyperuricaemia 
was not statistical different from those with normal 
serum uric acid level (P=0.46). Only fasting blood sugar 
showed a statistically significant difference in mean 
between subjects with hyperuricaemia and those with 
normouricaemia (P=0.02) as depicted in Table 2.
The mean serum uric acid was   337.58±94.59 mmol/l 
with a statistically significant higher mean for females 
( m a l e s  3 3 3 . 2 0 ± 8 8 . 7 0 ,  f e m a l e s  
339 .56±97 .21 ,p<0 .001) .The  preva lence  o f  









Age (years) 41.32±17.0 42.84±17.8 40.62±16.6 <0.001*








SBP (mmHg) 120.46±21.59 123.57±20.41 119.05±22.36 0.04*
DBP (mmHg) 73.86±12.63 75.52±13.03 73.25±12.30 0.50
FBG (mmol/L) 4.59±1.34 4.58±1.16 4.60±1.40 0.66
TC (mmol/L) 3.93±0.85 3.80±0.80 3.98±0.86 0.16
TG (mmol/L) 1.19±0.43 1.24±0.46 1.17±0.41 0.17
HDL (mmol/L) 1.01±0.19 1.01±0.20 1.01±0.22 0.45
LDL (mmol/L) 2.64±0.78 2.56±0.75  2.71±0.81 0.09
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Table 4: Pearson and Spearman’ rho correlation analysis for uric acid
*=significant  
Hyperuricemia was found in 86 out of the 500 subjects 
giving an overall prevalence of 17.2 % .The males had a 
statistically significant higher prevalence than the 
2 
females (males 25%, females 13.7%; x = 7.75, p= 
0.006). In the male sex, the highest rate was noted in the 
30-39 years age group with a declining pattern seen with 
increasing age unlike in the female gender that had the 
lowest prevalence in the 30-39 years age group and an 
increasing pattern with increasing age ( Figure 1).
According to table 3, a higher proportion of the subjects 
with hyperuricaemia compared with subjects with 
normouricaemia had hypertension, diabetes, impaired 
fasting glucose, hypertriglyceridaemia, abdominal 
2
obesity and BMI=25kg/m . However, these differences 
were not statistically significant except for 
hypertriglyceridaemia (P=0.03).
Pearson and Spearman' rho correlation analysis of serum 
uric acid with other parameters done for all the study 
subjects revealed that waist circumference, total 
cholesterol, low-density lipoprotein and gender had 
significant association with uric acid . Table 4 depicts 
this. 
Table 5 shows a multivariate logistic regression model 
for predicting hyperuricaemia. Only male gender was 
found to be a significant predictor for hyperuricaemia.
DISCUSSION
The high prevalence (17.2%) of hyperuricemia found in 
the present study is lower than previously reported by 
21-22
Isezuo etal and Ogbera et al in Nigeria.  This may be 
due to the fact that while the present study is a cross-
sectional rural community study, the comparative 
studies were among diabetics, urban and hospital-based. 
Diabetes is a well established risk factor for 
 
development of microvascular kidney disease that can 
28
predispose to hyperuricaemia.  Urbanisation and 
development of westernised lifestyle are also important 
factors implicated in the rising incidence of 
hyperuricaemia with subsequent development of renal 
6hypertension.
In agreement with previous studies, we found in the 
present study that the prevalence of hyperuricaemia was 
29-30significantly higher in males than in females  with the 
highest prevalence among the males noted in 30 to 
49years old age bracket similar to the findings by Conen 
31et al.  Subsequently, there was a declining prevalence 
    
    
    
    
    
    
    
    






















































Table 3: comparison of percentage of occurrence of parameters between subjects with normal and 
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seen with increasing age in males. This is contrary to 
what was found among the  female group were the 
lowest prevalence  was reported in the 30-39 years age 
group with an increasing pattern of prevalence seen with 
increasing age. The increasing prevalence seen in 
females with advancing age could be associated to the 
7,31
uricosuric effect of oestrogen.  Oestrogen which is a 
sex steroid in women is known to lower the plasma 
concentration of uric acid by enhancing its urinary 
excretion and as such with advancing age in women, 
menopause sets in and this uricosuric effect of oestrogen 
is lost and there is increase in plasma concentration of 
31    uric acid. Additional, Adamopoulos et al in their study, 
focused on the effect of hormone therapy (HT) on uric 
acid levels in post-menopausal women. In a majority of 
their study subjects they observed a fall in the plasma 
uric acid concentration following the administration of 
31
conjugated and synthetic eostrogen.  
According to the present study, a higher proportion of 
the subjects with hyperuricaemia compared with 
subjects with normouricaemia had hypertension, 
d i a b e t e s ,  i m p a i r e d  f a s t i n g  g l u c o s e ,  
hypertriglyceridaemia, abdominal obesity and 
2BMI=25kg/m . However, these were not statistically 
significant except for hypertriglyceridaemia 
(P=0.03).This points to the association of 
hyperuricaemia with insulin resistance and components 
of metabolic syndrome. Various researchers have also 
attributed hyperuricaemia to be a risk factor for the 
development of Type 2 DM while others see it as a 
32-33 
complication of DM. In our study, the mean fasting 
blood glucose was significantly higher in 
hyperuricaemic subjects. Hypertension was reported in 
22
55 % of hyperuricaemic subjects by Ogbera et al.  In the 
present study, hypertension occurred in 25.6% of the 
study subjects with hyperuricaemia. This finding in the 
present study depicts that the prevalence of hypertension 
is high in hyperuricaemia subjects. The Ogbera et al 
study was among diabetics as earlier stated and that 
could account for the higher percentage of hypertension 
among hyperuricaemic patient as diabetics are at higher 
 risk for microvascular kidney disease  and hence 
28hyperuricaemia.
Various researchers previously have reported a strong 
relationship between hypertriglycaeridaemia and 
hyperuricaemia pointing to the role of each of these 
27,34independently in cardiovascular disease risk.  This 
present  s tudy demonstrated prevalence of  
hypertriglycaeridaemia to be significantly higher in 
hyperuricaemic subjects than normouricaemic subjects. 
The correlation analyses for uric acid level showed that 
waist circumference, total cholesterol and low-density 
lipoprotein  and gender had significant association with 
uric acid while the logistic regression showed that the 
male gender was the only significant predictor of 
hyperuricaemia. In the work by Ebrahimpour et all, 
waist circumference and total cholesterol among others 
were also significantly correlated with uric acid in a 
35bivariate analysis.
 
The prevalence of hyperuricemia is high in this rural 
community with significantly higher prevalence in 
males than in females. In males the highest prevalence 
was noted in the younger age group and declined with 
advancing age contrary to the female gender that had the 
lowest prevalence in the younger age group and an 
increasing pattern with advancing age. A higher 
proportion of the subjects with hyperuricaemia 
compared with subjects with normouricaemia had 
hypertension, diabetes, impaired fasting glucose, 
hypertriglyceridaemia, abdominal obesity and 
2BMI=25kg/m . However, these were not statistically 
significant except for hypertriglyceridaemia. This 
points to the relationship between hyperuricaemia and 
insulin resistance with other components of metabolic 
syndrome. Pearson and Spearman' rho correlation 
analysis of serum uric acid with other parameters 
revealed that only waist circumference, total 
cholesterol, low-density lipoprotein and gender had 
significant association with uric acid and only male 
gender was found to be significant predictor for 
hyperuricaemia following a logistic regression. There is 
need for more research considering the cardiovascular 
and other implications of hyperuricaemia.
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